249 related articles for article (PubMed ID: 28495314)
1. A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses.
Won G; Kim B; Lee JH
Vaccine; 2017 Jun; 35(25):3333-3341. PubMed ID: 28495314
[TBL] [Abstract][Full Text] [Related]
2. Generation of a safety enhanced Salmonella Gallinarum ghost using antibiotic resistance free plasmid and its potential as an effective inactivated vaccine candidate against fowl typhoid.
Jawale CV; Chaudhari AA; Lee JH
Vaccine; 2014 Feb; 32(9):1093-9. PubMed ID: 24406393
[TBL] [Abstract][Full Text] [Related]
3. Construction of an inactivated typhoid vaccine candidate expressing
Kim B; Won G; Lee JH
J Med Microbiol; 2017 Aug; 66(8):1235-1243. PubMed ID: 28792376
[No Abstract] [Full Text] [Related]
4. A novel approach for the generation of Salmonella Gallinarum ghosts and evaluation of their vaccine potential using a prime-booster immunization strategy.
Jawale CV; Lee JH
Vaccine; 2014 Nov; 32(50):6776-82. PubMed ID: 25454861
[TBL] [Abstract][Full Text] [Related]
5. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
6. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
7. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses.
Das S; Chowdhury R; Ghosh S; Das S
Vaccine; 2017 Aug; 35(35 Pt B):4523-4531. PubMed ID: 28739115
[TBL] [Abstract][Full Text] [Related]
8. Construction of a Salmonella Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens.
Chaudhari AA; Jawale CV; Kim SW; Lee JH
Vet Res; 2012 May; 43(1):44. PubMed ID: 22620989
[TBL] [Abstract][Full Text] [Related]
9. Generation of a safe Salmonella Gallinarum vaccine candidate that secretes an adjuvant protein with immunogenicity and protective efficacy against fowl typhoid.
Nandre RM; Lee JH
Avian Pathol; 2014; 43(2):164-71. PubMed ID: 24689430
[TBL] [Abstract][Full Text] [Related]
10. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
11. Characterization of adaptive immune responses induced by a new genetically inactivated Salmonella Enteritidis vaccine.
Jawale CV; Lee JH
Comp Immunol Microbiol Infect Dis; 2014 May; 37(3):159-67. PubMed ID: 24878070
[TBL] [Abstract][Full Text] [Related]
12. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
13. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.
Wahid R; Pasetti MF; Maciel M; Simon JK; Tacket CO; Levine MM; Sztein MB
Clin Immunol; 2011 Feb; 138(2):187-200. PubMed ID: 21146460
[TBL] [Abstract][Full Text] [Related]
14. An immunogenic Salmonella ghost confers protection against internal organ colonization and egg contamination.
Jawale CV; Lee JH
Vet Immunol Immunopathol; 2014 Nov; 162(1-2):41-50. PubMed ID: 25241048
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.
Jawale CV; Chaudhari AA; Jeon BW; Nandre RM; Lee JH
Infect Immun; 2012 Apr; 80(4):1502-9. PubMed ID: 22290147
[TBL] [Abstract][Full Text] [Related]
16. Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: A prophylactic study in BALB/c mice.
Halder P; Maiti S; Banerjee S; Das S; Dutta M; Dutta S; Koley H
Vaccine; 2023 Sep; 41(41):5994-6007. PubMed ID: 37625993
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
Pakkanen SH; Kantele JM; Herzog C; Kantele A
Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
[TBL] [Abstract][Full Text] [Related]
19. A novel method to generate Salmonella Typhi Ty21a ghosts exploiting the λ phage holin-endolysin system.
Won G; Kim B; Lee JH
Oncotarget; 2017 Jul; 8(29):48186-48195. PubMed ID: 28637001
[TBL] [Abstract][Full Text] [Related]
20. Differential functional patterns of memory CD4
Salerno-Gonçalves R; Tettelin H; Luo D; Guo Q; Ardito MT; Martin WD; De Groot AS; Sztein MB
Vaccine; 2020 Jan; 38(2):258-270. PubMed ID: 31629569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
